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sequences faster than it is possible to discover their 
functions. Fortunately, combinatorial chemistry offers 
an opportunity to develop new biological reagents with 
which to determine the roles of related isozymes. 
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Few defining moments in science can be predicted years 
in advance. It is clear, however, that the completion of 
the several genome-sequencing projects that are currently 
under way will have a significant impact on almost every 
aspect of biology. While this may be one of the slowest and 
most highly observed paradigm shifts in recent scientific 
history, it will be profound. Once these projects are com- 
pleted, an enormous amount of information about new 
genes and gene families will become available. The first 
wave of this flood of data has already washed through; the 
first eukaryotic genome sequence, that of the yeast Sac& 
aronzyces ce~~isiue, was completed in April [ 11. This genome 
consists of 12 million base pairs containing an estimated 
6000 genes. The analysis of these new sequences and the 
discovery of new gene families has just begun. 
Coping with this flood of new information will be a chal- 
lenge, and one of the most difficult aspects will be assign- 
ing functions to previously unidentified proteins. As the 
first genome projects come to completion, attention is 
already beginning to shift away from the collection of 
sequence data towards trying to understand the function 
of the many new gene products discovered. This task is 
made more difficult by the fact that a significant number 
of these gene products are highly related to each other. 
Analysis of the yeast genome has revealed that 70 %  of 
yeast protein-coding sequences are related to known 
genes [l]. If this pattern holds for the estimated 80 000 
genes in the human genome, then there will be far more 
protein families than we currently know about, greatly 
increasing the intricacy of the already complex picture 
emerging from cell biology. More and more emphasis will 
therefore need to be placed on discovering the exact 
functions of a set of highly related protein family 
members or isozymes, ascertaining how much the duties 
of each family member overlap and determining whether 
individual members have distinct functions. Here, I 
discuss the shortcomings of current approaches to this 
problem, and suggest that combinatorial chemistry may 
offer an excellent solution. 
Identification is easy, determining function is hard 
When the problem of deciphering the function of a new 
protein arises, an obvious approach is to compare its 
amino acid sequence with the sequences of proteins of 
known function. Such analyses often reveal that domains 
whose function, in general terms, is known, are present 
within the new protein. Several molecular biology tech- 
niques have been developed to aid in the isolation of 
related gene sequences (e.g. low stringency DNA hybrid- 
ization and degenerate PCR), thus making broader com- 
parisons possible. It is often useful to define consensus 
sequences that are always present in all members of a 
given protein family, and then to use this consensus motif 
to identify additional family members. For example, the 
seminal paper on the kinase motif [Z] reported an align- 
ment of 65 different protein kinase amino acid sequences 
that revealed 11 conserved subdomains as being critical 
for kinase function. 
Not long ago, the identification of related gene products 
required weeks of work by a molecular biologist. Now, 
however, it is increasingly possible to find what one 
needs with a gene comparison search that takes only a 
few minutes at the computer terminal. For example, after 
the identification of a novel regulator of G-protein signal- 
ing (RGS) using a traditional genetic screen, a sequence 
comparison with known gene sequences in GenBank 
identified nine sequences related to RGS [3]. 
Although finding novel family members aids the recog- 
nition of novel conserved protein motifs, nowadays 
genes are often cloned before there is any information 
on the proteins they encode within the cell. Despite our 
ability to find sequence similarities between the new 
genes and those previously known, we cannot necessar- 
ily reach any useful conclusions about their functions. 
For example, the use of PCR and low stringency DNA 
hybridization has allowed the identification of a large 
number of putative steroid receptors based on sequence 
similarity, but the ligands for most of these orphan 
receptors are still unknown [4]. 
Making sense of signal transduction webs 
One area of cell biology in which isozyme redundancy is 
particularly noticeable is that of signal transduction. Over 
the past 20 years, researchers have made significant 
progress in, elucidating linear regulatory pathways (con- 
sisting of GTP-binding proteins, transcriptional activators 
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Figure 1 
Growth-factor receptor signal transduction links the binding of a 
growth factor to the external face of a cell with events within the 
nucleus. Ligand binding causes autophosphorylation of the receptor, 
allowing She and the adapter protein Grb2 to bind. Ras is then 
activated through GDP to GTP exchange, enabling it to bind to the Raf 
protein and recruit it to the plasma membrane. Raf then activates MEK,  
which in turn phosphorylates M A P  kinase, activating it and allowing it 
to phosphorylate a number of downstream targets. 
and protein kinase cascades) that link the binding of a 
growth factor to the external face of a cell with events 
within the nucleus (Fig. 1). After many years of work, 
these different components have been arranged in a hier- 
archical order, but this simple picture of linear pathways 
is now giving way to the idea that many isozyme regula- 
tory components are connected in a much more complex 
network or ‘web’. 
The threonine/tyrosine-specific kinase MEK exemplifies 
this increasing complexity. MEK links signaling events at 
the membrane with cytoplasmic protein phosphorylation. 
The first MEK protein was purified only four years ago 
based on a biochemical in vitro kinase assay [S]. Since 
then, five more related MEK sequences have been identi- 
fied using a variety of approaches [6]. Although MEKl 
was identified using its Zn vitro ability to phosphorylate 
and activate MAP kinase, it is becoming clear that differ- 
ent MEK proteins phosphorylate multiple MAP kinases, 
and that they are activated by different upstream kinases 
(Fig. 2). Deciphering the different roles of the various sig- 
naling components has taken many years and several false 
starts, partly because of the limitations of the approaches 
and tools that have been available. 
Current biological approaches and their inadequacies 
The number of enzymes that fall into closely related sets of 
isozymes is growing rapidly. Assigning functions to appar- 
ently redundant related protein family members is not 
easy. To determine the function of a single isozyme, what 
is needed is the ability to block (or increase) the action of 
just that one protein. All of the approaches currently avail- 
able to do this have certain advantages, although each has 
its own limitations. 
Gene knock-outs 
One of the most straightforward ways to understand a 
protein’s function is to eliminate it. This genetic approach 
is easy and informative in simple systems, but in mam- 
malian systems it has proven non-trivial. An effective 
method to eliminate a gene product from an animal is 
to remove the functioning gene from the genome. In 
mice, these are known as ‘knock-out’ experiments: mouse 
embryonic stem cells are genetically manipulated in vitro 
and then implanted into pseudopregnant female mice. 
Using this process, one can definitively eliminate a gene’s 
function. The procedure is costly and time consuming, 
however [7], and this technique therefore does not lend 
itself easily to a study of a large gene family. Moreover, 
expression of a given isozyme is often restricted to certain 
stages of development. Mice in which such an isozyme is 
knocked out may upregulate other isozymes to compen- 
sate for the loss, thereby complicating the interpretation of 
the experiment [S]. Thus, the generation of knock-out 
mice is clearly not the preferred approach to the study of 
large isozyme families. 
Gene transfection experiments 
Overexpression of genes introduced into cell cultures is 
widely used in cell biology to study the intracellular conse- 
quences of their expression. Genes can be introduced into 
cells either transiently (in which case the gene is not integ- 
rated into the cell’s genome and the protein product is 
therefore expressed only for a few days) or stably (which 
requires the gene to be stably integrated into the genome; 
this is accomplished by selecting for drug resistance). Stable 
integration has the advantage that all the cells selected from 
a single integration event express the same amount of the 
protein and can be expected to have stable gene expression 
for many cell generations. The process of gene integration, 
however, requires several weeks during which mutations 
can accumulate in the cell to compensate for any dele- 
terious effects that result from overexpression of the 
introduced gene. In addition, since gene integration is 
essentially random, some genes may be integrated close to 
strong gene promoters or transcriptional silencers, giving 
unpredictable expression levels. Thus, several transfectants 
must be tested to ensure an adequate level of expression. 
Since selection of stable transfectants is time-consuming 
and may result in cell lines that have adapted to the 
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Figure 2 
The increasing complexity of the regulatory 
pathways is exemplified by MEK. Six MEK 
proteins have now been identified. The MEK 
proteins are each phosphorylated by different 
upstream kinases and have themselves been 
shown to phosphorylate multiple MAP 
kinases. These patterns of phosphorylation 
overlap; for example MEKlIMEK2 are 
activated by MEKK3 and B-Raf [30,311, so 
the pathway forms a network instead of a 
simple linear path. 
presence of the foreign gene, many laboratories routinely 
use transient transfections instead. Transient overexpres- 
sion experiments are relatively easy to perform and give 
high levels of gene expression. For precisely this reason, 
however, these assays are inadequate for the study of the 
subtle functional differences expected between members 
of a family of isozymes. Overexpression of a given protein 
may result in isozyme-substrate interactions that do 
not normally occur in Z&O. The functional differences 
between related isozymes may derive from small differ- 
ences in their K, values for different substrates, and over- 
expression of one component may lead to activation of the 
wrong signaling cascade, resulting in spurious conclusions. 
This approach is, therefore, not suitable for the study of a 
signaling web consisting of various related isozymes. An 
unfortunate example that makes this clear is the story of 
the enzyme named MEK kinase (MEKKl). This kinase 
was cloned using sequence similarity with a yeast protein 
that activates an MEK homolog, and in vitro transient 
overexpression assays showed it to be able to phosphory- 
late MEKl. Based on these results, this gene was named 
MEKK, for MEK kinase [9]. Although MEKK can acti- 
vate MEKl/MEKZ in vitro, subsequent experiments have 
shown that the most likely downstream target of MEKK is 
not MEKl but a related homolog, MEK4 [lo]. It is clear 
that although transient overexpression experiments have 
been instrumental in determining signal hierarchies, they 
are inadequate for the investigation of isozyme function. 
Natural products as probes of cell biology 
Most cell biologists long for a ‘magic bullet’ that would 
specifically activate or inactivate their protein of interest, 
allowing them to shed light on the complexities of the cel- 
lular machinery. New approaches are needed to develop 
such reagents. They should allow transient perturbation of 
a cellular system and should distinguish clearly between 
related isozymes. Natural products provide one effective 
way to probe intracellular mechanisms [ll]. Recently, 
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immunosuppressive agents (such as FK506, rapamycin 
and cyclosporin A) that inactivate intracellular proteins 
(creating the equivalent of a gene that functions only 
under certain conditions, for example a permissive tem- 
perature, known as a ‘conditional allele’) have provided 
new insights into our understanding of immune cell regu- 
lation [l&13]. Other examples of natural products being 
used as molecular probes include the pertussis and cholera 
toxins, used in the study of GTP-binding proteins [14,1.5], 
and the conotoxins derived from marine snail venoms, 
used in the study of ion channels [16]. Natural products 
have helped to elucidate several cellular signaling path- 
ways, but the discovery of natural products that are spe- 
cific for any given protein is serendipitous. We would have 
to be lucky indeed to find a palette of natural products 
specific for every member of an isozyme family. 
Combinatorial chemistry - the solution? 
In the past, the pharmaceutical industry has screened and 
synthesized many specific inhibitors and activators of 
enzyme isozymes that are medically relevant. Unfortu- 
nately, the protein targets that are of interest to academic 
biologists in the development of new biological probes do 
not necessarily overlap with the interests of the pharmaceu- 
tical companies. In addition, the large financial and labor 
resources required takes this work out of the reach of most 
academic chemistry laboratories. Recent developments 
in the emerging field of molecular diversity are changing 
this picture, however, and hold much promise for the devel- 
opment of isozyme-specific probes as well as for future 
collaborations between academic chemists and biologists. 
Many academic laboratories have adapted molecular 
biology techniques to allow the generation of large sets of 
diverse molecules, which can then be used to identify 
novel ligands. For example, oligopeptide presentation on 
the surface of bacteriophage (phage display) has been suc- 
cessfully used to identify ligands for a variety of receptors 
and antibodies (for review see [17]). Similarly, expressed 
peptides have been used to identify ligands for cyclin- 
dependent kinase isoforms [18]. This was a novel 
approach to the selection of peptide ligands (now some- 
times known as peptide aptamers) from random peptide 
sequences in viva. Nucleic acid aptamers that bind selec- 
tively to given isozyme targets have also been reported 
[19,20]. The usefulness of these reagents in addressing 
questions in cell biology is in doubt, however, due to their 
inherent in &o susceptibility to degradation and their 
lack of cell-membrane permeability. In addition, the 
diversity represented by the 20 natural amino acids or 4 
natural bases is not enormous, and does not take advan- 
tage of the many small compounds that are common in 
modern organic chemistry. 
Fortunately, recent developments in combinatorial chem- 
istry offer much hope that new reagent development will 
soon become much easier. Combinatorial chemistry is not 
limited to a natural pool of monomers. Using the split/pool 
synthetic approach pioneered by Furka et al. [Zl], literally 
millions of compounds can be prepared by solid-phase 
synthesis with relative ease. These libraries of compounds 
can be screened for a variety of novel biological activities 
using a number of assays. ‘On-bead’, solution- and cell- 
based screening of libraries are becoming routine [ZZ]. 
These approaches have been used to successfully identify 
small ligands for protein domains such as SH’Z [23] and 
SH3 domains [24], opioid receptors [ZS] and benzodiazap- 
ine receptors [26]. Unlike rational drug design, which 
requires detailed structural information about a protein 
target, this approach of ‘irrational ligand design’ presents a 
very wide variety of possible ligands to the protein target 
and then detects the optimal ligand selected by the target. 
This approach is analogous to a genetic screen, in that 
selective pressure is applied to a pool of randomly 
mutated proteins to identify the few mutations that have 
the desired effect on the function of the protein. This 
combinatorial chemistry approach has been successful in 
identifying isozyme-selective inhibitors of carbonic anhy- 
drases and zinc endopeptidases [27,28], further suggesting 
that a similar approach would have the potential to yield 
new reagents that could distinguish between closely 
related members of a signaling family. 
The explosion of combinatorial chemistry in the past few 
years has fueled interest in the use of chemistry to address 
biological problems. Since combinatorial chemistry facili- 
tates the generation of many ligands for any given protein, 
one of its major applications has been in the field of molec- 
ular recognition. Although this has produced important 
new insights in protein-ligand interactions and has been of 
great interest to structural biologists, the opportunity to 
develop these ligands into practical biological tools is too 
often overlooked. More collaborations are now needed 
between chemists and biologists to take advantage of the 
many biological opportunities offered by combinatorial 
chemistry. In particular, the next phase in the developing 
story of molecular diversity generation should bring chem- 
istry into areas of biology (such as cell biology) that are not 
currently at the centre of the chemistry/biology interface 
1291. The emerging field of chemical biology will need to 
address problems in many biological areas in the post- 
genomic era. Combinatorial chemistry may come to the 
rescue by developing the wide range of novel reagents 
needed to address questions of isozyme function. 
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